Want to join the conversation?
During the nine months ended Sept. 30, 2015, $EQIX's revenues from US, the largest revenue contributor in the Americas region, represented 93% of the regional revenues; UK, the largest revenue contributor in the EMEA region, represented 38% of the regional revenues; and Singapore, the largest revenue contributor in the APAC region, represented 39%.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.